$LNSR

LENSAR (NASDAQ: LNSR) updates 10-K with governance, pay and control data

LENSAR, Inc. (NASDAQ: LNSR) has filed an Amendment No. 1 to its annual report (Form 10-K/A) to include comprehensive Part III disclosures, which detail information on directors, executive compensation, ownership, related-party transactions, and auditor fees for the fiscal year ended December 31, 2025. The filing clarifies that North Run Capital and affiliates beneficially own approximately 55% of LENSAR's common stock and hold 45.1% of combined voting power, stemming from a $20.0 million investment in Series A Convertible Preferred Stock and warrants made in 2024. The amendment also outlines the 2025 compensation for key executives, with CEO Nicholas T. Curtis receiving over $2.3 million.

Original reporting
Published May 1, 2026, 12:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 1, 2026, 12:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$LNSR
Neutral
medium confidence
Mentioned
$LNSR · $LNSR
alphai data visualization · based on Stock Titan
Decision brief

The 30-second read

$LNSRNeutralLow
01

Why it matters

The disclosure clarifies major ownership stakes and executive compensation, which could influence investor perceptions and long-term stability.

02

Market read

While important for long-term stakeholders, the news has limited immediate trading impact for short-term traders.

03

What to watch

Potential future changes in ownership structure or executive compensation policies could alter the company's strategic direction.

Timing: long-term

Background

LENSAR recently filed an amendment to its annual report, providing detailed disclosures on governance, ownership, and executive pay for fiscal year ending December 31, 2025.

Company-level read

Ticker impact

$LNSRNeutralMedium confidence
Context

The news pertains directly to LENSAR's corporate governance, ownership structure, and executive compensation, which are significant factors for long-term investors and institutional stakeholders.

Expected impact

Minimal short-term price movement expected; potential for long-term stability or volatility depending on corporate governance developments.

Evidence & confidence

While the disclosure clarifies ownership and compensation, it does not indicate immediate operational changes or market-moving events.

$LNSRNeutralMedium confidence
Context

The news is highly relevant for long-term investors and institutional traders interested in corporate governance and ownership structures.

Expected impact

No significant immediate impact; potential for gradual influence on stock performance.

Evidence & confidence

The information enhances understanding of company control but lacks immediate catalysts for trading actions.

Market effects

The disclosures may reinforce governance standards within the life sciences sector, potentially influencing peer companies.

Limited regional impact; primarily relevant to U.S. markets and institutional investors.

Low; specific to company and sector-level considerations.

Counterpoint

Some investors may view increased ownership concentration as a potential risk for minority shareholders, possibly leading to governance concerns.

Key entities

  • North Run Capital

    A significant investor holding approximately 55% of LENSAR's common stock.

  • Nicholas T. Curtis

    CEO of LENSAR, received over $2.3 million in compensation for 2025.

Related articles

$LNSRMedAI 9/10

Lensar (LNSR) Q4 2025 Earnings Transcript

Lensar reported Q4 2025 revenue of $16 million, down 4% mainly from lower system sales, including weaker sales outside the U.S. The company placed 15 ALLY systems (12 U.S., 1 outside) and grew its installed base to just over 200 ALLY systems (+48%). Recurring revenue rose 17% to $12.7 million (79% of Q4 revenue). Gross margin was 43% ($6.9 million). Management said the Alcon acquisition termination restored independence and full title to a $10 million deposit; 2026 cash operating expenses are ex

$DISMed

Disney, Comcast reach deal, lifting NFL Network blackout

Comcast and Disney reached an agreement to end the NFL Network blackout for Comcast Xfinity TV subscribers, resuming NFL Network and NFL RedZone in time for the 2026 season. The blackout began after their contract expired in late April. Disney owns 72% of ESPN, which took over NFL Media assets earlier this year. Terms were not disclosed.

$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

$IONQMedAI 8/10

Pentagon may see one of quantum computing’s first practical winners

IonQ (IONQ) said DARPA awarded a $28 million contract modification under its It’s About Time program to support production development and 25 Evergreen-05 optical atomic clocks, with a $30 million option for 100 additional clocks. IonQ plans to invest $15 million to scale manufacturing. The company cites timing performance for GPS-denied defense uses.

$CCEYFMedAI 8/10

CanCambria Energy Provides Updated Contingent Resource Evaluation for Flagship Deep Gas Project, Attributable to Strong European Natural Gas Prices, Driving an Increased NPV10 of US$2.04 Billion

CanCambria Energy Corp. (TSXV: CCEC) reported an updated independent contingent resource evaluation for its 100% owned Kiskunhalas deep gas project in southern Hungary. Prepared by CHPE (effective June 30, 2026), it assumes $12.00/MMBtu TTF1 gas. Risked 2C Development Pending NPV10 rose 16% to US$2.04B from US$1.762B; 2C volumes are 571.9 Bcf and 59.6 MMbbl. First gas is targeted for mid-2027.